FDA Label for Dimenhydrinate
View Indications, Usage & Precautions
Dimenhydrinate Product Label
The following document was submitted to the FDA by the labeler of this product Carilion Materials Management. The document includes published materials associated whith this product with the essential scientific information about this product as well as other prescribing information. Product labels may durg indications and usage, generic names, contraindications, active ingredients, strength dosage, routes of administration, appearance, warnings, inactive ingredients, etc.
Active Ingredient (In Each Tablet)
Dimenhydrinate 50 mg
Purpose
Antiemetic
Ask A Doctor Before Use If You Have
- a breathing problem such as emphysema or chronic bronchitis
- glaucoma
- difficulty in urination due to enlargement of the prostate gland
When Using This Product
- marked drowsiness may occur
- alcohol, sedatives and tranquilizers may increase drowsiness
- avoid alcoholic drinks
- be careful when driving a motor vehicle or operating machinery
Keep Out Of Reach Of Children.
In case of overdose, get medical help or contact a Poison Control Center right away. (1-800-222-1222).
Directions
- to prevent motion sickness, the first dose should be taken 1/2 to 1 hour before starting activity
- to prevent or treat motion sickness, use the following dosing
adults and children 12 years and over
| 1-2 tablets every 4-6 hours; not more than 8 tablets in 24 hours, or as directed by a doctor
|
children 6 years to under 12 years
| 1/2-1 tablet every 6-8 hours; not more than 3 tablets in 24 hours, or as directed by a doctor
|
children 2 years to under 6 years
| 1/4-1/2 tablet every 6-8 hours; not more than 1 1/2 tablets in 24 hours, or as directed by a doctor
|
Other Information
store at 15° to 30°C (59° to 86°F)
You may report serious side effects to: . 130 Vintage Drive, Huntsville, AL 35811
Inactive Ingredients
colloidal silicone dioxide, lactose monohydrate, magnesium stearate, microcrystalline cellulose, sodium starch glycolate, stearic acid
* Please review the disclaimer below.